Literature DB >> 26908829

The effects of apolipoprotein B depletion on HDL subspecies composition and function.

W Sean Davidson1, Anna Heink2, Hannah Sexmith2, John T Melchior1, Scott M Gordon3, Zsuzsanna Kuklenyik4, Laura Woollett1, John R Barr4, Jeffrey I Jones4, Christopher A Toth5, Amy S Shah6.   

Abstract

HDL cholesterol (HDL-C) efflux function may be a more robust biomarker of coronary artery disease risk than HDL-C. To study HDL function, apoB-containing lipoproteins are precipitated from serum. Whether apoB precipitation affects HDL subspecies composition and function has not been thoroughly investigated. We studied the effects of four common apoB precipitation methods [polyethylene glycol (PEG), dextran sulfate/magnesium chloride (MgCl2), heparin sodium/manganese chloride (MnCl2), and LipoSep immunoprecipitation (IP)] on HDL subspecies composition, apolipoproteins, and function (cholesterol efflux and reduction of LDL oxidation). PEG dramatically shifted the size distribution of HDL and apolipoproteins (assessed by two independent methods), while leaving substantial amounts of reagent in the sample. PEG also changed the distribution of cholesterol efflux and LDL oxidation across size fractions, but not overall efflux across the HDL range. Dextran sulfate/MgCl2, heparin sodium/MnCl2, and LipoSep IP did not change the size distribution of HDL subspecies, but altered the quantity of a subset of apolipoproteins. Thus, each of the apoB precipitation methods affected HDL composition and/or size distribution. We conclude that careful evaluation is needed when selecting apoB depletion methods for existing and future bioassays of HDL function.

Entities:  

Keywords:  cholesterol efflux; dextran sulfate; heparin sodium; high density lipoprotein; lipoproteins; low density lipoprotein; polyethylene glycol; proteomics

Mesh:

Substances:

Year:  2016        PMID: 26908829      PMCID: PMC4808776          DOI: 10.1194/jlr.M066613

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  38 in total

1.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.

Authors:  G R Warnick; J J Albers
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

2.  Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol.

Authors:  G R Warnick; T Nguyen; A A Albers
Journal:  Clin Chem       Date:  1985-02       Impact factor: 8.327

3.  Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome.

Authors:  Fabiana Rached; Raul D Santos; Laurent Camont; Marcio H Miname; Marie Lhomme; Carolane Dauteuille; Sora Lecocq; Carlos V Serrano; M John Chapman; Anatol Kontush
Journal:  J Lipid Res       Date:  2014-10-23       Impact factor: 5.922

4.  A rapid and simple quantification of human apolipoprotein E-rich high-density lipoproteins in serum.

Authors:  H Chiba; K Akizawa; S Fujisawa; T Osaka-Nakamori; N Iwasaki; H Suzuki; S Intoh; K Matsuno; T Mitamura; K Kobayashi
Journal:  Biochem Med Metab Biol       Date:  1992-02

5.  Two-step mechanism of binding of apolipoprotein E to heparin: implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces.

Authors:  Miho Futamura; Padmaja Dhanasekaran; Tetsurou Handa; Michael C Phillips; Sissel Lund-Katz; Hiroyuki Saito
Journal:  J Biol Chem       Date:  2004-12-06       Impact factor: 5.157

6.  Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography.

Authors:  Scott M Gordon; Jingyuan Deng; L Jason Lu; W Sean Davidson
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

7.  Immunoprecipitation of apolipoprotein B-containing lipoproteins for isolation of HDL particles.

Authors:  John H Contois; Andre L Albert; Rae-Anne Nguyen
Journal:  Clin Chim Acta       Date:  2014-06-30       Impact factor: 3.786

8.  Polyethylene glycol interferes with protein molecular weight determinations by gel filtration.

Authors:  S B Yan; D A Tuason; V B Tuason; W H Frey
Journal:  Anal Biochem       Date:  1984-04       Impact factor: 3.365

9.  Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial.

Authors:  Michiel L Bots; Frank L Visseren; Gregory W Evans; Ward A Riley; James H Revkin; Charles H Tegeler; Charles L Shear; William T Duggan; Ralph M Vicari; Diederick E Grobbee; John J Kastelein
Journal:  Lancet       Date:  2007-07-14       Impact factor: 79.321

10.  Macrophage cholesterol efflux correlates with lipoprotein subclass distribution and risk of obstructive coronary artery disease in patients undergoing coronary angiography.

Authors:  Patrick Linsel-Nitschke; Henning Jansen; Zouhair Aherrarhou; Stefanie Belz; Björn Mayer; Wolfgang Lieb; Fritz Huber; Werner Kremer; Hans-Robert Kalbitzer; Jeanette Erdmann; Heribert Schunkert
Journal:  Lipids Health Dis       Date:  2009-04-06       Impact factor: 3.876

View more
  22 in total

1.  Plasma lipoprotein-X quantification on filipin-stained gels: monitoring recombinant LCAT treatment ex vivo.

Authors:  Lita A Freeman; Robert D Shamburek; Maureen L Sampson; Edward B Neufeld; Masaki Sato; Sotirios K Karathanasis; Alan T Remaley
Journal:  J Lipid Res       Date:  2019-02-26       Impact factor: 5.922

2.  Interparticle Molecular Exchange of Surface Chemical Components of Native High-Density Lipoproteins to Complementary Nanoparticle Scaffolds.

Authors:  Kaylin M McMahon; Andrea E Calvert; Irina S Dementieva; Saber Hussain; John T Wilkins; C Shad Thaxton
Journal:  ACS Sens       Date:  2020-07-14       Impact factor: 7.711

3.  High Free Cholesterol Bioavailability Drives the Tissue Pathologies in Scarb1-/- Mice.

Authors:  Jing Liu; Baiba K Gillard; Dedipya Yelamanchili; Antonio M Gotto; Corina Rosales; Henry J Pownall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-08-12       Impact factor: 10.514

4.  Alcohol Consumption and Cardiovascular Health.

Authors:  Chayakrit Krittanawong; Ameesh Isath; Robert S Rosenson; Muzamil Khawaja; Zhen Wang; Sonya E Fogg; Salim S Virani; Lu Qi; Yin Cao; Michelle T Long; Christy C Tangney; Carl J Lavie
Journal:  Am J Med       Date:  2022-05-14       Impact factor: 5.928

5.  ABCA1-Derived Nascent High-Density Lipoprotein-Apolipoprotein AI and Lipids Metabolically Segregate.

Authors:  Bingqing Xu; Baiba K Gillard; Antonio M Gotto; Corina Rosales; Henry J Pownall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-10-26       Impact factor: 8.311

6.  High density lipoprotein proteome is associated with cardiovascular risk factors and atherosclerosis burden as evaluated by coronary CT angiography.

Authors:  Scott M Gordon; Jonathan H Chung; Martin P Playford; Amit K Dey; Denis Sviridov; Fayaz Seifuddin; Yun-Ching Chen; Mehdi Pirooznia; Marcus Y Chen; Nehal N Mehta; Alan T Remaley
Journal:  Atherosclerosis       Date:  2018-09-25       Impact factor: 5.162

7.  Feasibility of a plasma bioassay to assess oxidative protection of low-density lipoproteins by high-density lipoproteins.

Authors:  Debi K Swertfeger; Sandra Rebholz; Hailong Li; Amy S Shah; William Sean Davidson; Long J Lu
Journal:  J Clin Lipidol       Date:  2018-08-27       Impact factor: 4.766

Review 8.  The Difference Between High Density Lipoprotein Subfractions and Subspecies: an Evolving Model in Cardiovascular Disease and Diabetes.

Authors:  W Sean Davidson; Allison L Cooke; Debi K Swertfeger; Amy S Shah
Journal:  Curr Atheroscler Rep       Date:  2021-03-27       Impact factor: 5.113

9.  Association of Cholesterol Efflux Capacity With Clinical Features of Metabolic Syndrome: Relevance to Atherosclerosis.

Authors:  Julie Gall; Eric Frisdal; Randa Bittar; Wilfried Le Goff; Eric Bruckert; Philippe Lesnik; Maryse Guerin; Philippe Giral
Journal:  J Am Heart Assoc       Date:  2016-11-23       Impact factor: 5.501

10.  Correlates and Predictors of Cerebrospinal Fluid Cholesterol Efflux Capacity from Neural Cells, a Family of Biomarkers for Cholesterol Epidemiology in Alzheimer's Disease.

Authors:  Eleonora Cipollari; Hannah J Szapary; Antonino Picataggi; Jeffrey T Billheimer; Catherine A Lyssenko; Gui-Shuang Ying; Leslie M Shaw; Mitchel A Kling; Rima Kaddurah-Daouk; Daniel J Rader; Domenico Praticò; Nicholas N Lyssenko
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.